| 51 | 10576649 | The acridonecarboxamide GF120918 potently reverses P-glycoprotein-mediated resistance in human sarcoma MES-Dx5 cells. | Br J Cancer | 1999 Nov |
2 |
| 52 | 10601617 | Clofazimine and B4121 sensitize an intrinsically resistant human colon cancer cell line to P-glycoprotein substrates. | Oncol Rep | 2000 Jan-Feb |
3 |
| 53 | 10604261 | Mechanisms of action of taxanes in prostate cancer. | Semin Oncol | 1999 Oct |
1 |
| 54 | 10604264 | A phase II trial of docetaxel (Taxotere) in hormone-refractory prostate cancer: correlation of antitumor effect to phosphorylation of Bcl-2. | Semin Oncol | 1999 Oct |
2 |
| 55 | 10606283 | Targeting bcl-2 gene to delay androgen-independent progression and enhance chemosensitivity in prostate cancer using antisense bcl-2 oligodeoxynucleotides. | Urology | 1999 Dec |
2 |
| 56 | 10615229 | Docetaxel compared with sequential methotrexate and 5-fluorouracil in patients with advanced breast cancer after anthracycline failure: a randomised phase III study with crossover on progression by the Scandinavian Breast Group. | Eur J Cancer | 1999 Aug |
1 |
| 57 | 10639573 | NADPH/quinone oxidoreductase is a priority target of glioblastoma chemotherapy. | Int J Oncol | 2000 Feb |
3 |
| 58 | 10665657 | Interaction of docetaxel ("Taxotere") with human P-glycoprotein. | Jpn J Cancer Res | 1999 Dec |
14 |
| 59 | 10675076 | Colitis associated with docetaxel-based chemotherapy in patients with metastatic breast cancer. | Lancet | 2000 Jan 22 |
1 |
| 60 | 10687988 | Dexamethasone does not significantly contribute to the response rate of docetaxel and estramustine in androgen independent prostate cancer. | J Urol | 2000 Mar |
1 |
| 61 | 10697568 | Taxotere activates transcription factor AP-1 in association with apoptotic cell death in gastric cancer cell lines. | Anticancer Res | 1999 Nov-Dec |
8 |
| 62 | 10699926 | Late apoptotic effects of taxanes on K562 erythroleukemia cells: apoptosis is delayed upstream of caspase-3 activation. | Int J Cancer | 2000 Feb 15 |
3 |
| 63 | 10699953 | Resistance to taxanes is induced by c-erbB-2 overexpression in human MCF-10A mammary epithelial cells and is blocked by combined treatment with an antisense oligonucleotide targeting type I protein kinase A. | Int J Cancer | 2000 Mar 1 |
2 |
| 64 | 10737719 | Non-ionic detergent Tween 80 modulates VP-16 resistance in classical multidrug resistant K562 cells via enhancement of VP-16 influx. | Cancer Lett | 2000 Feb 28 |
2 |
| 65 | 10767372 | Cell cycle status and apoptosis of hematopoietic progenitor cells released into the peripheral blood after taxanes and granulocyte colony-stimulating factor in breast cancer patients. | Oncol Rep | 2000 May-Jun |
1 |
| 66 | 10769693 | Enhancement of chemotherapeutic agents induced-apoptosis associated with activation of c-Jun N-terminal kinase 1 and caspase 3 (CPP32) in bax-transfected gastric cancer cells. | Anticancer Res | 2000 Jan-Feb |
2 |
| 67 | 10778948 | The effect of an individual's cytochrome CYP3A4 activity on docetaxel clearance. | Clin Cancer Res | 2000 Apr |
5 |
| 68 | 10810400 | Single agent docetaxel plus granulocyte-colony stimulating factor (G-CSF) in previously treated patients with advanced non small cell lung cancer. A phase II study and review of the literature. | Anticancer Res | 2000 Mar-Apr |
1 |
| 69 | 10810934 | Docetaxel (Taxotere) in HER-2-positive patients and in combination with trastuzumab (Herceptin). | Semin Oncol | 2000 Apr |
2 |
| 70 | 10811471 | Synergistic effects of adenovirus expressing wild-type p53 on chemosensitivity of non-small cell lung cancer cells. | Cancer Gene Ther | 2000 Apr |
1 |
| 71 | 10829051 | Correlation between docetaxel clearance and estimated cytochrome P450 activity by urinary metabolite of exogenous cortisol. | J Clin Oncol | 2000 Jun |
2 |
| 72 | 10871820 | Phase I/II dose escalation study of docetaxel and carboplatin combination supported with amifostine and GM-CSF in patients with incomplete response following docetaxel chemo-radiotherapy: additional chemotherapy enhances regression of residual cancer. | Med Oncol | 2000 May |
1 |
| 73 | 10914699 | Role of intestinal P-glycoprotein in the plasma and fecal disposition of docetaxel in humans. | Clin Cancer Res | 2000 Jul |
3 |
| 74 | 10945505 | Proteolysis of microtubule associated protein 2 and sensitivity of pancreatic tumours to docetaxel. | Br J Cancer | 2000 Aug |
2 |
| 75 | 10948319 | Enhancement of immunohistochemical reactivity for thymidine phosphorylase in breast carcinoma cells after administration of docetaxel as a neoadjuvant chemotherapy in advanced breast cancer patients. | Oncol Rep | 2000 Sep-Oct |
5 |
| 76 | 10955790 | Predictive value of p53, mdm-2, p21, and mib-1 for chemotherapy response in advanced breast cancer. | Clin Cancer Res | 2000 Aug |
2 |
| 77 | 10955859 | Frontline treatment of advanced gastric cancer with docetaxel and granulocyte colony-stimulating factor (G-CSF): a phase II trial. | Am J Clin Oncol | 2000 Aug |
1 |
| 78 | 10963840 | Second-line chemotherapy for recurrent non-small cell lung cancer: do new agents make a difference? | Lung Cancer | 2000 Aug |
2 |
| 79 | 10999771 | In vitro evaluation of schedule-dependent interactions between docetaxel and doxorubicin against human breast and ovarian cancer cells. | Clin Cancer Res | 2000 Sep |
2 |
| 80 | 11001384 | Differential impact of Raf-1 kinase activity on tumor cell resistance to paclitaxel and docetaxel. | Anticancer Drugs | 2000 Jul |
3 |
| 81 | 11002234 | Docetaxel-induced lymphopenia in patients with solid tumors: a prospective phenotypic analysis. | Cancer | 2000 Sep 15 |
5 |
| 82 | 11019836 | Docetaxel effectively mobilizes peripheral blood CD34+ cells. | Bone Marrow Transplant | 2000 Sep |
3 |
| 83 | 11029783 | Regulation of interleukin-6 secretion from breast cancer cells and its clinical implications. | Breast Cancer | 2000 |
2 |
| 84 | 11057324 | [Antitumor activity of UFT and docetaxel on human breast carcinoma xenografts]. | Gan To Kagaku Ryoho | 2000 Oct |
1 |
| 85 | 11097380 | Cytotoxicity of cyclophosphamide, paclitaxel, and docetaxel for tumor cell lines in vitro: effects of concentration, time and cytochrome P450-catalyzed metabolism. | Arch Toxicol | 2000 Oct |
6 |
| 86 | 11102737 | Modulation of oral bioavailability of anticancer drugs: from mouse to man. | Eur J Pharm Sci | 2000 Dec |
2 |
| 87 | 11103243 | [Effectiveness of docetaxel plus cisplatin in large cell lung cancer showing little response to prior chemotherapy with MVP]. | Gan To Kagaku Ryoho | 2000 Nov |
1 |
| 88 | 11124653 | Chemotherapy-induced noncardiogenic pulmonary edema related to gemcitabine plus docetaxel combination with granulocyte colony-stimulating factor support. | Respiration | 2000 |
1 |
| 89 | 11138457 | Phase I study of docetaxel and topotecan in patients with solid tumors. | Cancer Chemother Pharmacol | 2000 |
2 |
| 90 | 11156248 | Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase. | Clin Cancer Res | 2000 Dec |
1 |
| 91 | 11160641 | Human CYP1B1 and anticancer agent metabolism: mechanism for tumor-specific drug inactivation? | J Pharmacol Exp Ther | 2001 Feb |
1 |
| 92 | 11177597 | Mobilization of peripheral blood stem cells in high-risk breast cancer patients using G-CSF after standard dose docetaxel. | J Hematother Stem Cell Res | 2000 Dec |
2 |
| 93 | 11181682 | Coadministration of cyclosporine strongly enhances the oral bioavailability of docetaxel. | J Clin Oncol | 2001 Feb 15 |
5 |
| 94 | 11182366 | Different docetaxel-induced apoptotic pathways are present in prostate cancer cell lines LNCaP and PC-3. | Urology | 2001 Feb |
6 |
| 95 | 11212279 | Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels. | Cancer Res | 2001 Jan 15 |
3 |
| 96 | 11265409 | [A case of recurrent breast cancer successfully treated with docetaxel]. | Gan To Kagaku Ryoho | 2001 Mar |
1 |
| 97 | 11309294 | The antiangiogenic property of docetaxel is synergistic with a recombinant humanized monoclonal antibody against vascular endothelial growth factor or 2-methoxyestradiol but antagonized by endothelial growth factors. | Cancer Res | 2001 Apr 15 |
6 |
| 98 | 11329060 | The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. | Nat Med | 2001 May |
1 |
| 99 | 11329786 | [A case of docetaxel-resistant breast cancer responsive to paclitaxel therapy]. | Gan To Kagaku Ryoho | 2001 Apr |
1 |
| 100 | 11335876 | Efficacy of monochemotherapy with docetaxel (taxotere) in relation to prolactin secretion in heavily pretreated metastatic breast cancer. | Neuro Endocrinol Lett | 2001 |
2 |